Global Health Game-Changer: Japan’s Universal Artificial Blood Enters Human Trials
Developed to overcome blood type mismatches and storage limitations, artificial blood trials in Japan could reshape emergency and disaster response medicine globally
In a world where the mismatch between medical needs and available resources often determines life or death, the development of universal artificial blood is not merely a scientific milestone—it is a humanitarian imperative. March 2025 saw researchers at Nara Medical University (Japan) embark on a pioneering clinical trial: testing lab-engineered artificial blood that's universally compatible and stable for up to two years.
Keep reading with a 7-day free trial
Subscribe to Technicity to keep reading this post and get 7 days of free access to the full post archives.